Strides Pharma (India) Today
| STAR Stock | 702.20 36.30 5.45% |
PerformanceWeak
| Odds Of DistressLow
|
Strides Pharma is selling for under 702.20 as of the 23rd of March 2025; that is 5.45 percent increase since the beginning of the trading day. The stock's lowest day price was 664.6. Strides Pharma has less than a 16 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Strides Pharma is entity of India. It is traded as Stock on NSE exchange. The company has 92.16 M outstanding shares. More on Strides Pharma Science
Moving against Strides Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Strides Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Strides Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Strides Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President Markets | Jitesh Devendra | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Strides Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Strides Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsStrides Pharma can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Strides Pharma's financial leverage. It provides some insight into what part of Strides Pharma's total assets is financed by creditors.
| |||||
Strides Pharma Science (STAR) is traded on National Stock Exchange of India in India and employs 3,065 people. Strides Pharma is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 64.72 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Strides Pharma's market, we take the total number of its shares issued and multiply it by Strides Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Strides Pharma Science operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 92.16 M outstanding shares.
Strides Pharma generates positive cash flow from operations, but has no cash available
Check Strides Pharma Probability Of Bankruptcy
Ownership AllocationStrides Pharma Science shows a total of 92.16 Million outstanding shares. Strides Pharma Science maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Strides Ownership Details
Strides Pharma Science Risk Profiles
Although Strides Pharma's alpha and beta are two of the key measurements used to evaluate Strides Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.7 | |||
| Semi Deviation | 2.98 | |||
| Standard Deviation | 3.48 | |||
| Variance | 12.11 |
Strides Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Strides Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Strides Pharma Corporate Management
Elected by the shareholders, the Strides Pharma's board of directors comprises two types of representatives: Strides Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Strides. The board's role is to monitor Strides Pharma's management team and ensure that shareholders' interests are well served. Strides Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Strides Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Manjula Ramamurthy | Compliance Secretary | Profile | |
| Christoph Funke | Chief Officer | Profile | |
| P Ramaraju | Chief Officer | Profile | |
| Lakshmi Narayanan | Chief Officer | Profile |
Additional Tools for Strides Stock Analysis
When running Strides Pharma's price analysis, check to measure Strides Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Strides Pharma is operating at the current time. Most of Strides Pharma's value examination focuses on studying past and present price action to predict the probability of Strides Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Strides Pharma's price. Additionally, you may evaluate how the addition of Strides Pharma to your portfolios can decrease your overall portfolio volatility.